

| Status | Official Title | Lead Investigator | Last Updated |
|---|---|---|---|
| Finalised | Pattern of use of incretin-based drugs in clinical practice | Dr Roberto Giuseppe | 14/02/2019 |
| Finalised | Surveillance of Adverse Event related to childhood vaccination reported by parents | Professor Moretti Ugo | 12/02/2019 |
| Ongoing | Dulaglutide Modified-Prescription-Event Monitoring Study and network database study: a multi-database collaborative research program of observational studies to monitor the utilisation and safety of dulaglutide in the EU | Professor Saad Shakir | 02/09/2019 |
| Planned | The BRodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) study in electronic healthcare databases |
Professor Jesper Hallas | 07/10/2020 |
| Planned | Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines | Dr Caitlin Dodd | 22/09/2020 |
| Planned | Time to treatment intensification in patients receiving metformin+incretin-based medicines versus metformin+other hypoglicemics | Dr Roberto Giuseppe | 14/02/2019 |